Pulmonary Cell News Volume 15.08 | May 7 2026

    0
    33






    2026-05-07 | PULCN 15.08


    Pulmonary Cell News by STEMCELL Technologies
    Vol. 15.08 – 07 May, 2026
    TOP STORY

    A Ginsenoside Metabolite and Its Derivative Target PRELID3B against Lung Cancer Cells

    Researchers developed an efficacious compound K (CK) derivative, CKD-4 with significantly enhanced cancer cell penetration and cytotoxicity both in vitro and in vivo.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract
    PUBLICATIONSListed by the impact factor of the journal

    Endothelial GDF15 Deficiency Enhances Barrier Function and Mitigates Pulmonary Fibrosis

    Scientists demonstrated that plasma growth differentiation factor 15 (GDF15) is elevated across diverse fibrotic lung disease subtypes and correlates with markers of elevated right heart pressures, but not pulmonary function indices, indicating a possible link to endothelial cell dysfunction.
    [JCI Insight]

    Abstract

    TGF-β Coordinates Alanine Synthesis and Import for Myofibroblast Differentiation in Pulmonary Fibrosis

    Researchers identified alanine as an essential metabolite for myofibroblast differentiation. Transforming growth factor–β1 (TGF-β) increases intracellular alanine levels through enhanced synthesis and import in both normal and idiopathic pulmonary fibrosis lung fibroblasts.
    [JCI Insight]

    Abstract | Graphical Abstract

    Discovery and Evaluation of a PROTAC Degrader Targeting SAMHD1 for the Treatment of Pulmonary Fibrosis

    The authors reported the discovery of NP12, the first SAMHD1 degrader with intracellular activity. In a bleomycin-induced pulmonary fibrosis mouse model, NP12 delayed pulmonary fibrosis progression and exerted a protective effect on lung tissue.
    [Journal of Medicinal Chemistry]

    Abstract | Graphical Abstract

    Long Isoforms of the COPD Risk Gene FAM13A Orchestrate Human Lung Epithelial Development

    Investigators demonstrated that the FAM13A long isoform is critical to patterning NKX2-1 + lung progenitor cells through dysregulating Wnt/β-catenin signaling during early stages of development in vitro.
    [American Journal of Respiratory Cell and Molecular Biology]

    Abstract

    Functionalised Thin Multi-Walled Carbon Nanotubes Are Less Toxic to Lung Cells In Vitro Than Their Native Counterparts

    Scientists investigated the induction of the epithelial-mesenchymal transition of human bronchial epithelial cells BEAS-2B following six weeks of treatment with multi-walled carbon nanotubes ranging from 0.125 to 1 µg/cm2.
    [Archives of Toxicology]

    Abstract

    LDHC4 Drives Lung Adenocarcinoma Progression by Inducing Lactylation of RB1 at Lysine 900 to Disrupt the RB1-E2F1 Complex

    Researchers investigated whether lactate dehydrogenase C4 (LDHC4) promotes lung adenocarcinoma by modulating protein lactylation, a lactate-derived post-translational modification, focusing on the tumor suppressor retinoblastoma protein (RB1).
    [Journal of Translational Medicine]

    Abstract | Graphical Abstract
    A gloved hand holding an EasySep™ EV isolation kit vial with text reading “The Easy Choice for EV Isolation” and “Request a Free EV Kit Sample.”
    REVIEWS

    Emerging Role of SIRT1 in Asthma and COPD from Molecular Mechanisms to Translational Therapy

    The authors examines challenges, compare SIRT1’s divergent roles, and evaluate chronotherapy, biomarker-guided selection, and SIRT1 activators.
    [iScience]

    Abstract | Graphical Abstract
    INDUSTRY AND POLICY NEWS

    Nuvation Bio Announces FDA Acceptance of Supplemental New Drug Application for IBTROZI® (taletrectinib) with Updated Duration of Response in Advanced ROS1-Positive Non-Small Cell Lung Cancer

    Nuvation Bio, Inc. announced today that the US FDA has accepted a supplemental New Drug Application with updated data for IBTROZI® (taletrectinib) in both TKI-naïve and TKI-pretreated advanced ROS1-positive NSCLC.
    [Nuvation Bio, Inc.]

    Press Release
    FEATURED EVENT

    EACR 2026 Congress: Innovative Cancer Science

    June 8-11, 2026
    Budapest, Hungary

    > See All Events

    JOB OPPORTUNITIES

    Research Group Leader – Cardiopulmonary Molecular Biology

    Medical University of Vienna – Vienna, Austria

    Postdoctoral Fellow- Genome Editing and Gene Therapy

    The Icahn School of Medicine at Mount Sinai – New York City, New York, United States

    Postdoctoral Fellowships – Computational Biology

    The University of Texas MD Anderson Cancer Center – Houston, Texas, United States

    Assistant/Associate/Full Professor – Cardiovascular & Pulmonary Physiology

    Indiana University – Indianapolis, Indiana, United States

    Full Professorship – Early Cancer Detection

    Heidelberg University – Heidelberg, Germany

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2